The Role of National Cancer Institute–Designated Cancer Center Status
- 1 May 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 255 (5) , 890-895
Abstract
Objective: We sought to evaluate differences in guideline concordance between National Cancer Institute (NCI)–designated and other centers and determine whether the level of available evidence influences the degree of variation in concordance. Background: The National Cancer Institute recognizes centers of excellence in the advancement of cancer care. These NCI-designated cancer centers have been shown to have better outcomes for cancer surgery; however, little work has compared surgical process measures. Methods: A retrospective cohort study was conducted using Surveillance, Epidemiology and End Results registry linked to Medicare claims data. Fee-for-service Medicare patients with a definitive surgical resection for breast, colon, gastric, rectal, or thyroid cancers diagnosed between 2000 and 2005 were identified. Claims data from 1999 to 2006 were used. Our main outcome measure was guideline concordance at NCI-designated centers compared to other institutions, stratified by level of evidence as graded by National Comprehensive Cancer Network guideline panels. Results: All centers achieved at least 90%, and often 95%, concordance with guidelines based on level 1 evidence. Concordance rates for guidelines with lower-level evidence ranged from 30% to 97% and were higher at NCI-designated centers. The adjusted concordance ratios for category 1 guidelines were between 1.02 and 1.08, whereas concordance ratios for guidelines with lower-level evidence ranged from 0.97 to 2.19, primarily favoring NCI-designated centers. Conclusions: When strong evidence supports a guideline, there is little variation in practice between NCI-designated centers and other hospitals, suggesting that all are providing appropriate care. Variation in care may exist, however, for guidelines that are based on expert consensus rather than strong evidence. This suggests that future efforts to generate needed evidence on the optimal approach to care may also reduce institutional variation.Keywords
This publication has 43 references indexed in Scilit:
- Receipt of Appropriate Surgical Care for Medicare Beneficiaries With CancerArchives of Surgery, 2011
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2011
- Hospital characteristics, clinical severity, and outcomes for surgical oncology patientsSurgery, 2010
- Comparison of Sentinel Lymph Node Biopsy Alone and Completion Axillary Lymph Node Dissection for Node-Positive Breast CancerJournal of Clinical Oncology, 2009
- The role of the surgeon in whether patients with lymph node‐positive colon cancer see a medical oncologistCancer, 2007
- Completion of Therapy by Medicare Patients With Stage III Colon CancerJNCI: Journal of the National Cancer Institute, 2006
- Axillary Recurrence After Sentinel Node BiopsyAnnals of Surgical Oncology, 2004
- The case for knowledge translation: shortening the journey from evidence to effectBMJ, 2003
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987